Cancer Biomarkers Market Worth $28.2 Billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnostics, R&D, Prognostics), Region - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 28.2 billion by 2026 from USD 12.4 billion in 2021, at a CAGR of 17.7%.
View full press release